Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood - Fetal and Neonatal Edition 2006;91:F7-F10; doi:10.1136/adc.2004.063925
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Waal, K A
Right arrow Articles by Offringa, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Waal, K A
Right arrow Articles by Offringa, M

ORIGINAL ARTICLE

Systematic review of the optimal fluid for dilutional exchange transfusion in neonatal polycythaemia

K A de Waal1, W Baerts1, M Offringa2

1 Department of Paediatrics, Division of Neonatology, Isala Clinics Zwolle, Zwolle, The Netherlands
2 Department of Neonatology, Emma Children’s Hospital, Academic Medical Centre, Amsterdam, The Netherlands

Correspondence to:
Correspondence to:
Koert A de Waal
Department of Neonatal Medicine, Royal Prince Albert Hospital, Missenden Road, Camperdown, NSW 2050, Australia; k.a.dewaal{at}amc.uva.nl

Objectives: Several studies have shown the efficacy of dilutional exchange transfusion (DET) in reducing haematocrit (Ht) and relieving clinical symptoms in neonatal polycythaemia. We conducted a systematic review to determine the efficacy of crystalloid versus colloid solutions used in DET in an effort to identify the best solution to replace red blood cells.

Methods: The Cochrane Library, MEDLINE, and EMBASE were searched for relevant randomised controlled trials. Quality assessment and data analysis were performed using the methods and software of the Cochrane Collaboration. Relative risk (RR) and weighted mean difference (WMD) were calculated as measures of effect for categorical and continuous outcome data, respectively. Ninety five percent confidence intervals (95% CI) were calculated and a fixed effect model was used for meta-analysis.

Results: Six studies with a total of 235 newborns matched our inclusion criteria. When comparing crystalloid and colloid replacement solutions for DET, there was a clinically unimportant difference in Ht at 2–6 h and at 24 h in favour of colloidal solutions (WMD 2.29% (95% CI 1.28 to 3.31) and 1.74% (95% CI 0.80 to 2.68), respectively). This difference in post DET Ht was more evident when normal saline was compared to plasma but absent when normal saline was compared to 5% albumin.

Conclusion: There is little difference in effectiveness between plasma, 5% albumin, and crystalloid solutions. Since normal saline is cheap, readily available, and does not carry the potential risk of transfusion associated infection, normal saline is the optimal dilutional fluid for exchange transfusion in polycythaemic neonates.


Abbreviations: 95% CI, 95% confidence interval; DET, dilutional exchange transfusion; Ht, haematocrit; PC, polycythaemia; RR, relative risk; WMD, weighted mean difference

Keywords: blood viscosity; infant; newborn; plasma exchange; polycythaemia; systematic review







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health